Becker's ASC Review

March/April 2021 Issue of Becker's ASC Review

Issue link: https://beckershealthcare.uberflip.com/i/1344616

Contents of this Issue

Navigation

Page 77 of 79

78 HEALTHCARE NEWS ADVERTISINGINDEX Note: Ad page number(s) given in parentheses ADVERTISER Ansell. ansell.com/pi-kare-beckers (pg. 79) Bone Foam. sales@bonefoam.com / bonefoam.com/hippy / (877) 861-2663 (pg. 13) Compulink Healthcare Solutions. compulinkadvantage.com/smart-asc / (805) 716-8688 (pg. 15) Innomed. info@innomed.net / innomed.net / (912) 236-0000 (pg. 65) Innovative Medical Products. impmedical.com / (800) 467-4944 (pg. 57) Innovative Sterilization Technologies. onetray.com / (937) 619-0138 (pg. 2) Mizuho OSI. mizuhosi.com/hanasc (pg. 63) National Medical Billing Services. nationalascbilling.com / (866) 948-8001 (pg. 80) OutcomeMD. rsaliman@outcomemd.com / calendly.com/rsaliman (pg. 43) Owens & Minor. halyardhealth.com (pgs. 50-52) Pacira BioSciences. exparel.com/reimbursement / (855) 793-9727 (pgs. 9-10) PE GI Solutions. pegisolutions.com / (866) 240-9496 (pgs. 60-61) ProAssurance. proassurance.com (pg. 41) Smith+Nephew. think-aria.com / think-positive-connections.com (pgs. 20-26) Stryker. stryker.com/asc (pg. 3) Zimmer Biomet. ascsolutions@zimmerbiomet.com / zimmerbiomet.com/asc (pgs. 36-39) 20 most expensive prescription drugs in 2021 By Katie Adams D rug prices in the U.S. are about 256 per- cent higher than those in other countries, according to recent research. Below is a list of the 20 most expensive prescrip- tion drugs in the U.S., based on the official price their manufacture assigned to them, as compiled by prescription discount company GoodRx. is list excludes medications that must be adminis- tered by a healthcare practitioner. Zokinvy (Eiger BioPharmaceuticals): $86,040 Myalept (Aegerion Pharmaceuticals): $74,159 Mavenclad (EMD Serono): $60,371 Ravicti (Horizon erapeutics): $57,998 Actimmune (Horizon erapeutics): $55,310 Oxervate (Dompé): $48,498 Takhzyro (Takeda): $46,828 Juxtapid (Aegerion Pharmaceuticals): $46,502 Cinryze (Takeda): $45,465 Chenodal (Travere erapeutics): $42,570 Gattex (Takeda): $41,664 H.P. Acthar (Mallinckrodt Pharmaceuticals): $39,864 Orladeyo (BioCryst Pharmaceuticals): $37,308 Tegsedi (Akcea erapeutics): $35,638 Ayvakit (Blueprint Medicines): $33,568 Vitrakvi (Bayer Pharmaceuticals): $32,800 Qinlock (Decipera Pharmaceuticals): $32,000 Korlym (Corcept erapeutics): $31,440 Cerdelga (Genzyme): $28,599 Idhifa (Celgene): $28,246 n

Articles in this issue

Links on this page

view archives of Becker's ASC Review - March/April 2021 Issue of Becker's ASC Review